Mapping large numbers of results may take a few moments.
Search Results
Showing 501 - 537 of 537 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company TregTherapeutics Inc. | Activity: Research and Development | Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. | Location Chapel Hill | |
Company Triangle Biotechnology Inc. | Activity: Research and Development | Company Description Triangle Biotechnology develops sonication reagents that enable efficient acoustic processing of biological samples for next generation sequencing and epigenetic assays. | Location Research Triangle Park | |
Company TriboFilm Research Inc. | Activity: Research and Development | Company Description TriboFilm Research develops low-friction, thin-film coating and lubrication platforms for medical devices. | Location Raleigh | |
Company TyraTech Inc. | Activity: Research and Development | Company Description TyraTech develops and commercializes plant-derived non-toxic insecticides and green solutions for humans, animals and agricultural applications. | Location Morrisville | |
Company Ummino | Activity: Research and Development | Company Description Ummino is developing technology that uses precision fermentation to fortify food and beverage products and restore and repair the microbiome. | Location Raleigh | |
Company Upstream Biotechnology Inc. | Activity: Research and Development | Company Description Upstream Biotechnology uses patented technology to develop broad-spectrum disease resistant crops to eliminate pesticide use, reduce production cost and increase crop yield. | Location Sanford | |
Company URO-1 Inc. | Activity: Research and Development | Company Description URO-1 develops breakthrough products for office procedures for urology and urogynecology, which improve clinical outcomes, enhance patient experience and increase procedure efficiency. | Location Greensboro | |
Company ValanBio Therapeutics Inc. | Activity: Research and Development | Company Description Valanbio Therapeutics is an early-stage anti-infectives company. Valanbio is developing novel antibiotics for Gram-negative organisms. | Location Durham | |
Company Vascular BioSciences Inc. | Activity: Research and Development | Company Description Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. | Location Durham | |
Company Vast Therapeutics | Activity: Research and Development | Company Description Vast Therapeutics uses a nitric oxide technology for the treatment of cystic fibrosis and other respiratory diseases. | Location Durham | |
Company Velo Bio LLC | Activity: Research and Development | Company Description Velo Bio is developing an orphan drug for the treatment of severe preeclampsia in pregnant women. | Location Morrisville | |
Company Verb Biotics LLC | Activity: Research and Development | Company Description Verb Biotics identifies and designs new strains of probiotics and postbiotics for nutrition, health and wellness. | Location Durham | |
Company Verinetics Inc. | Activity: Research and Development | Company Description Verinetics is commercializing platform technology that makes dispensing controlled substance pharmaceuticals safer for patients and their providers. | Location Research Triangle Park | |
Company Vero Diagnostics LLC | Activity: Contract Research and Testing | Company Description Vero Diagnostics offers comprehensive diagnostic testing, including urine and oral fluid drug monitoring, pathogen detection, Pharmacogenomics (PGx) testing and blood testing. | Location Apex | |
Company Vestaron Corp. | Activity: Sales and Operations | Company Description Vestaron develops and manufactures peptide-based biopesticides. | Location Durham | |
Company Viamer Biosciences | Activity: Research and Development | Company Description Viamer Biosciences develops advanced and proprietary biomaterials for controlled release drug delivery and regenerative medical devices. | Location Durham | |
Company Vijaya Pharmaceuticals LLC | Activity: Contract Research and Testing | Company Description Vijaya Pharmaceuticals provides medicinal and synthetic organic chemistry services to the pharmaceutical and allied industries. | Location Research Triangle Park | |
Company ViraSource LLC | Activity: Contract Research and Testing | Company Description ViraSource propagates and purifies BSL-1, BSL-2 viruses and bacteriophages. ViraSource also provides virus modifications and animal models of viral infections and antiviral immune responses. | Location Durham | |
Company ViraTree LLC | Activity: Production and Manufacturing | Company Description ViraTree acquires, authenticates, preserves, develops and distributes virological materials, information and technology for the advancement of virus research. | Location Research Triangle Park | |
Company ViroKyne Therapeutics LLC | Activity: Research and Development | Company Description Virokyne is developing novel therapies for the treatment of viral diseases. | Location Durham | |
Company Vital Plan Inc. | Activity: Research and Development | Company Description Vital Plan formulates and produces natural supplements and herbal therapies that support immune health, microbiome balance, and healthy aging. | Location Raleigh | |
Company VitriStor LLC | Activity: Research and Development | Company Description VitriStor is developing technologies to produce large quantities of hepatocytes (liver cells) on demand for cell therapy, regenerative medicine and pharmaceutical applications. | Location Charlotte | |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill | |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham | |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point | |
Company Xenobiotic Detection Systems International Inc. | Activity: Contract Research and Testing | Company Description Xenobiotic Detection Systems offers patented bioassays to facilitate assessment of environmental and human health risks. | Location Durham | |
Company Xollent Biotech Inc. | Activity: Research and Development | Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. | Location Cary | |
Company Xona Microfluidics Inc. | Activity: Research and Development | Company Description Xona Microfluidics develops and manufactures microfluidic platforms for neuroscience research. | Location Research Triangle Park | |
Company Xsome Biotech Inc. | Activity: Research and Development | Company Description Xsome Biotech is developing inhalable vaccines using a lung-derived exosome. | Location Cary | |
Company Xyzagen Inc. | Activity: Contract Research and Testing | Company Description Xyzagen is a non-GLP LC-MS/MS bioanalytical lab with rodent in vivo pharmacokinetics and pharmacology research vivarium. Xyzagen also offers clinical pharmacology/pharmokinetics and GLP toxicokinetic support. | Location Pittsboro | |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill | |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill | |
Company Zoion Pharma Inc. | Activity: Research and Development | Company Description Zoion Pharma develops drugs for veterinary disorders. Zoion's lead product is an epithelial sodium channel blocker compound to treat canine keratoconjunctivitis sicca (KCS) or dry eye. | Location Raleigh | |
Company Zorbius Biopharma Inc. | Activity: Contract Research and Testing | Company Description Zorbius Biopharma provides analytical, formulation and nanotechnology-related services to pharmaceutical, biotech and medical device companies. | Location Morrisville | |
Company ZY Therapeutics Inc. | Activity: Research and Development | Company Description ZY Therapeutics is developing a drug delivery platform for cancer therapeutics using nanotechnology. | Location Research Triangle Park | |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham | |
Company Zymtronix Inc. | Activity: Research and Development | Company Description Zymtronix provides technology that can enable and improve any biocatalytic reaction involving single enzymes or cell-free systems of multiple enzymes. Zymtronix offers solutions for various industries, including agriculture, life sciences, and ingredients. | Location Research Triangle Park |